BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qualman SJ, Morotti RA. Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification. Curr Oncol Rep 2002;4:123-30. [PMID: 11822984 DOI: 10.1007/s11912-002-0073-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Pytel P, Cipriani NA. Soft Tissue and Bone Neoplasms. Molecular Pathology Library 2018. [DOI: 10.1007/978-3-319-89626-7_9] [Reference Citation Analysis]
2 Rhabdomyosarcoma. Diagnostic Pathology: Pediatric Neoplasms 2018. [DOI: 10.1016/b978-0-323-54806-9.50067-7] [Reference Citation Analysis]
3 Milewski D, Pradhan A, Wang X, Cai Y, Le T, Turpin B, Kalinichenko VV, Kalin TV. FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor. Oncogene 2017;36:850-62. [PMID: 27425595 DOI: 10.1038/onc.2016.254] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
4 Kurmasheva RT, Hosoi H, Kikuchi K, Houghton PJ. Molecular Therapy for Rhabdomyosarcoma. Molecularly Targeted Therapy for Childhood Cancer 2010. [DOI: 10.1007/978-0-387-69062-9_20] [Reference Citation Analysis]
5 López-terrada D, Hicks JM. Genetics and Molecular Biology of Bone and Soft Tissue Tumors. Bone Pathology 2009. [DOI: 10.1007/978-1-59745-347-9_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Krishnan B, Khanna G, Clohisy D. Gene translocations in musculoskeletal neoplasms. Clin Orthop Relat Res 2008;466:2131-46. [PMID: 18566876 DOI: 10.1007/s11999-008-0342-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
7 RHABDOMYOSARCOMA. Atlas of Head and Neck Pathology 2008. [DOI: 10.1016/b978-0-7216-9788-8.50047-2] [Reference Citation Analysis]
8 Thomas Stocker J, Husain AN, Dehner LP. Pediatric Tumors. Dail and Hammar’s Pulmonary Pathology 2008. [DOI: 10.1007/978-0-387-72114-9_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
9 PRIMITIVE NEUROECTODERMAL TUMOR (PNET)/EWING SARCOMA (ES). Atlas of Head and Neck Pathology 2008. [DOI: 10.1016/b978-0-7216-9788-8.50049-6] [Reference Citation Analysis]
10 Somers GR, Gupta AA, Doria AS, Ho M, Pereira C, Shago M, Thorner PS, Zielenska M. Pediatric undifferentiated sarcoma of the soft tissues: a clinicopathologic study. Pediatr Dev Pathol 2006;9:132-42. [PMID: 16822084 DOI: 10.2350/08-05-0098.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
11 Hoffman HT, Robinson RA, Spiess JL, Buatti J. Update in management of head and neck sarcoma: . Current Opinion in Oncology 2004;16:333-41. [DOI: 10.1097/01.cco.0000127880.69877.75] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
12 Chang CC, Shidham VB. Molecular genetics of pediatric soft tissue tumors: clinical application. J Mol Diagn 2003;5:143-54. [PMID: 12876204 DOI: 10.1016/S1525-1578(10)60466-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]